Colorectal Cancer and Prostaglandin
Journal of the Korean Society of Coloproctology
;
: 52-59, 2003.
Article
Dans Coréen
| WPRIM
| ID: wpr-225620
ABSTRACT
The possibility for cyclooxygenase (COX) inhibitors in colorectal cancer prevention and theraphy is evident from epidemiologic data (reduction of colorectal cancer in nonsteroidal anti-inflammatory drugs (NSAIDs) users), animal experiments (nude mouse xenograft tumor reduced by NSAIDs or reduction of colorectal cancer in APCmin mouse and azoxymethane treated rat by using NSAIDs), and molecular genetics. Among two variant COX, inducible COX-2 enzyme is more involved in tumorigenesis than constitutive COX-1 enzyme and molecular method have given us insight into the mechanism of colorectal cancer development by COX-2 such as, apoptosis, angiogenesis, invasiveness, and immune modulation. Based on that COX-2 is involved in tumor promotion during colorectal cancer progress, a large number of prevention and treatment trials of colorectal cancer have been started. And many trials to elucidate the function of prostaglandin produced by COX-2 are now in progress.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Oxyde de diméthyl-diazène
/
Tumeurs colorectales
/
Anti-inflammatoires non stéroïdiens
/
Prostaglandin-endoperoxide synthases
/
Apoptose
/
Expérimentation animale
/
Cyclooxygenase 2
/
Hétérogreffes
/
Carcinogenèse
/
Biologie moléculaire
Limites du sujet:
Animaux
langue:
Coréen
Texte intégral:
Journal of the Korean Society of Coloproctology
Année:
2003
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS